Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.
$1,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.
- The patient must be getting treatment for immune thrombocytopenic purpura.
- The patient must have Medicare health insurance that covers his or her qualifying medication or product.
- The patient’s medication or product must be listed on PAN’s list of covered medications.
- Patient must be required to travel greater than 20 miles (one way) to receive their prescribed treatment. Exceptions to distance requirements are made for patients living in large metropolitan cities.
- The patient’s income must fall at or below 400% of the Federal Poverty Level.
- The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
Travel Assistance Program Details
PAN offers travel assistance for patients seeking treatment for Idiopathic Thrombocytopenic Purpura. Our Travel Assistance will cover approved mileage and parking reimbursement and will provide patients with a high-touch service model that assists in the scheduling of their travel needs.
- » The fund will cover mileage and parking to medical appointments related to approved therapy as determined by the prescribing physician.
- » An appointment with the healthcare provider must be scheduled prior to arranging transportation.
- » Patients must be approved for travel assistance at least two business days in advance of the appointment to ensure travel means are available.
See the list of medications covered in this program
- Active Injection Kit D (dexamethasone sodium phosphate/pf)
- A-Hydrocort (hydrocortisone sod succinate)
- A-Methapred (methylprednisolone sodium succinate)
- Bivigam (immune globulin, gamm(igg)/glycine/iga greater than 50 mcg/ml)
- Carimune Nf Nanofiltered (immune globulin, gamm(igg)/sucrose/iga greater than 50 mcg/ml)
- Cortef (hydrocortisone)
- Cortisone Acetate (cortisone acetate)
- Deltasone (prednisone)
- Dexamethasone Intensol (dexamethasone)
- Dexpak (dexamethasone)
- Doptelet (avatrombopag maleate)
- Doubledex (dexamethasone sodium phosphate/pf)
- Flebogamma Dif (immune globulin, gamma (igg)/sorbitol/iga 0 to 50 mcg/ml)
- Flo-Pred (prednisolone acetate)
- Gamastan S-D (immune globulin, gamma(igg)/glycine)
- Gammagard S-D (immune globulin, gamm(igg)/glycine/glucose/iga 0 to 50 mcg/ml)
- Gammaked (immune globulin, gamma(igg)/glycine/iga average 46 mcg/ml)
- Gammaplex (immune globulin, gamm(igg)/sorbitol/glycin/iga 0 to 50 mcg/ml)
- Gamunex (immune globulin, gamm(igg)/glycine/iga greater than 50 mcg/ml)
- Methylprednisolone (methylprednisolone)
- Millipred (prednisolone)
- Mulpleta (lusutrombopag)
- Nplate (romiplostim)
- Octagam (immune globulin, gamm(igg)/maltose/iga greater than 50 mcg/ml)
- Orapred Odt (prednisolone sod phosphate)
- Pediapred (prednisolone sod phosphate)
- Prednisolone (prednisolone)
- Prednisone (prednisone)
- Prelone (prednisolone)
- Privigen (immune globulin, gamma (igg)/proline/iga 0 to 50 mcg/ml)
- Promacta (eltrombopag olamine)
- Rayos (prednisone)
- Rhophylac (rho(d) immune globulin)
- Rituxan (rituximab)
- Solu-Cortef (hydrocortisone sodium succinate/pf)
- Solu-Medrol (methylprednisolone sodium succinate/pf)
- Tavalisse (fostamatinib disodium)
- Veripred 20 (prednisolone sod phosphate)
- Winrho Sdf (rho(d) immune globulin/maltose)